Class Action Filed Against ESSA Pharma Inc. (EPIX) Seeking Recovery for Investors - Contact Levi & Korsinsky — Neutral
EPIX Accesswire — February 10, 2025NEW YORK, NY / ACCESS Newswire / February 10, 2025 / If you suffered a loss on your ESSA Pharma Inc. (NASDAQ:EPIX) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/essa-pharma-inc-lawsuit-submission-form?prid=128436&wire=1 or contact Joseph E. Levi, Esq.
Big pharma has come under a lot of scrutiny from regulators and consumers as sentiment sours on the industry. As such, the market can be unforgiving when companies even slightly miss expectations or forecasts.
Pacira BioSciences, Inc. Sued for Securities Law Violations - Contact Levi & Korsinsky Before March 14, 2025 to Discuss Your Rights - PCRX — Neutral
PCRX Accesswire — February 10, 2025NEW YORK, NY / ACCESS Newswire / February 10, 2025 / If you suffered a loss on your Pacira BioSciences, Inc. (NASDAQ:PCRX) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/pacira-biosciences-inc-lawsuit-submission-form?prid=128435&wire=1 or contact Joseph E. Levi, Esq.
February 14, 2025 Deadline: Contact Levi & Korsinsky to Join Class Action Suit Against MGPI — Neutral
MGPI Accesswire — February 10, 2025NEW YORK, NY / ACCESS Newswire / February 10, 2025 / If you suffered a loss on your MGP Ingredients, Inc. (NASDAQ:MGPI) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/mgp-ingredients-inc-lawsuit-submission-form?prid=128437&wire=1 or contact Joseph E. Levi, Esq.
Class Action Filed Against TELUS International (Cda) Inc. (TIXT) - March 31, 2025 Deadline to Join - Contact Levi & Korsinsky — Neutral
TIXT Accesswire — February 10, 2025NEW YORK, NY / ACCESS Newswire / February 10, 2025 / If you suffered a loss on your TELUS International (Cda) Inc. (NYSE:TIXT) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/telus-international-lawsuit-submission-form?prid=128438&wire=1 or contact Joseph E. Levi, Esq.
Levi & Korsinsky Reminds FTAI Aviation Ltd. Investors of the Pending Class Action Lawsuit with a Lead Plaintiff Deadline of March 18, 2025 - FTAI — Neutral
FTAI Accesswire — February 10, 2025NEW YORK, NY / ACCESS Newswire / February 10, 2025 / If you suffered a loss on your FTAI Aviation Ltd. (NASDAQ:FTAI) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/ftai-aviation-ltd-lawsuit-submission-form?prid=128426&wire=1 or contact Joseph E.
Regeneron Pharmaceuticals, Inc. Class Action: Levi & Korsinsky Reminds Regeneron Investors of the Pending Class Action Lawsuit with a Lead Plaintiff Deadline of March 10, 2025 - REGN — Neutral
REGN Accesswire — February 10, 2025NEW YORK, NY / ACCESS Newswire / February 10, 2025 / If you suffered a loss on your Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/regeneron-pharmaceuticals-inc-lawsuit-submission-form?prid=128427&wire=1 or contact Joseph E. Levi, Esq.
Integral Ad Science Holding Corp. Class Action: Levi & Korsinsky Reminds Integral Ad Science Investors of the Pending Class Action Lawsuit with a Lead Plaintiff Deadline of March 31, 2025 - IAS — Neutral
IAS Accesswire — February 10, 2025NEW YORK, NY / ACCESS Newswire / February 10, 2025 / If you suffered a loss on your Integral Ad Science Holding Corp. (NASDAQ:IAS) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/integral-ad-science-lawsuit-submission-form?prid=128441&wire=1 or contact Joseph E. Levi, Esq.
Levi & Korsinsky Reminds Shareholders of a Lead Plaintiff Deadline of March 31, 2025 in Walgreens Lawsuit - WBA — Neutral
WBA Accesswire — February 10, 2025NEW YORK, NY / ACCESS Newswire / February 10, 2025 / If you suffered a loss on your Walgreens Boots Alliance, Inc. (NASDAQ:WBA) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/walgreens-boots-alliance-inc-lawsuit-submission-form-2?prid=128430&wire=1 or contact Joseph E. Levi, Esq.
Levi & Korsinsky Investigates Possible Securities Fraud Violations by CARGO Therapeutics, Inc. (CRGX) — Neutral
CRGX Accesswire — February 10, 2025NEW YORK, NY / ACCESS Newswire / February 10, 2025 / Levi & Korsinsky notifies investors that it has commenced an investigation of CARGO Therapeutics, Inc. ("CARGO Therapeutics, Inc.") (NASDAQ:CRGX) concerning possible violations of federal securities laws. On January 29, 2025, CARGO announced in a press release that it "has elected to discontinue FIRCE-1, a Phase 2 clinical study of firi-cel for patients with large B-cell lymphoma (LBCL) whose disease relapsed or was refractory (R/R) to CD19 CAR T-cell therapy.
Cardlytics, Inc. Class Action: Levi & Korsinsky Reminds Cardlytics Investors of the Pending Class Action Lawsuit with a Lead Plaintiff Deadline of March 25, 2025 - CDLX — Neutral
CDLX Accesswire — February 10, 2025NEW YORK, NY / ACCESS Newswire / February 10, 2025 / If you suffered a loss on your Cardlytics, Inc. (NASDAQ:CDLX) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/cardlytics-lawsuit-submission-form?prid=128432&wire=1 or contact Joseph E. Levi, Esq.
Lost Money on GSK plc(GSK)? Join Class Action Suit Seeking Recovery - Contact Levi & Korsinsky — Neutral
GSK Accesswire — February 10, 2025NEW YORK, NY / ACCESS Newswire / February 10, 2025 / If you suffered a loss on your GSK plc (NYSE:GSK) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/gsk-lawsuit-submission-form?prid=128434&wire=1 or contact Joseph E. Levi, Esq.
Micron Technology, Inc. Sued for Securities Law Violations - Investors Should Contact Levi & Korsinsky for More Information - MU — Neutral
MU Accesswire — February 10, 2025NEW YORK, NY / ACCESS Newswire / February 10, 2025 / If you suffered a loss on your Micron Technology, Inc. (NASDAQ:MU) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/micron-technology-inc-lawsuit-submission-form?prid=128421&wire=1 or contact Joseph E. Levi, Esq.
Class Action Filed Against Monolithic Power Systems Inc. (MPWR) - April 7, 2025 Deadline to Join - Contact Levi & Korsinsky — Neutral
MPWR Accesswire — February 10, 2025NEW YORK, NY / ACCESS Newswire / February 10, 2025 / If you suffered a loss on your Monolithic Power Systems Inc. (NASDAQ:MPWR) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/monolithic-lawsuit-submission-form?prid=128422&wire=1 or contact Joseph E. Levi, Esq.
Levi & Korsinsky Notifies Shareholders of Nextracker Inc. (NXT) of a Class Action Lawsuit and an Upcoming Deadline — Neutral
NXT Accesswire — February 10, 2025NEW YORK, NY / ACCESS Newswire / February 10, 2025 / If you suffered a loss on your Nextracker Inc. (NASDAQ:NXT) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/nextracker-inc-lawsuit-submission-form?prid=128428&wire=1 or contact Joseph E. Levi, Esq.
Levi & Korsinsky Reminds Newmont Investors of the Pending Class Action Lawsuit with a Lead Plaintiff Deadline of April 1, 2025 - NEM — Neutral
NEM Accesswire — February 10, 2025NEW YORK, NY / ACCESS Newswire / February 10, 2025 / If you suffered a loss on your Newmont Corporation (NYSE:NEM) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/newmont-corporation-lawsuit-submission-form?prid=128423&wire=1 or contact Joseph E. Levi, Esq.
Class Action Filed Against Grocery Outlet Holding Corp. (GO) - March 31, 2025 Deadline to Join - Contact Levi & Korsinsky — Neutral
GO Accesswire — February 10, 2025NEW YORK, NY / ACCESS Newswire / February 10, 2025 / If you suffered a loss on your Grocery Outlet Holding Corp. (NASDAQ:GO) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/grocery-outlet-holding-corp-lawsuit-submission-form?prid=128443&wire=1 or contact Joseph E. Levi, Esq.
Contact Levi & Korsinsky by March 25, 2025 Deadline to Join Class Action Against Novo Nordisk A/S (NVO) — Neutral
NVO Accesswire — February 10, 2025NEW YORK, NY / ACCESS Newswire / February 10, 2025 / If you suffered a loss on your Novo Nordisk A/S (NYSE:NVO) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/novo-nordisk-a-s-lawsuit-submission-form?prid=128444&wire=1 or contact Joseph E. Levi, Esq.
Shareholder Rights Advocates at Levi & Korsinsky Investigate e.l.f. Beauty, Inc. (ELF) Regarding Possible Securities Fraud Violations — Neutral
ELF Accesswire — February 10, 2025NEW YORK, NY / ACCESS Newswire / February 10, 2025 / Levi & Korsinsky notifies investors that it has commenced an investigation of e.l.f. Beauty, Inc. ("e.l.f.
IDEXX Laboratories stock has shown consistent long-term annualized growth of 24.75%. Despite a tough year with a 20% loss, IDEXX remains strong, fundamentally. IDEXX's innovative products and international growth offset declining US clinical visits, projecting an 11.54% annual EPS growth over the next five years.
